Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Carrier Screening - Comprehensive Panel (145 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 185 | 145 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
COL7A1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 7 | 1 |
|
MMP1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Carrier Screening Guidelines-Based Panel Ambry Genetics United States | 199 | 165 |
|
Centogene AG - the Rare Disease Company Germany | 157 | 151 |
|
Invitae Epidermolysis Bullosa and Palmoplantar Keratoderma Panel Invitae United States | 95 | 45 |
|
Invitae Inborn Errors of Immunity and Cytopenias Panel Invitae United States | 755 | 562 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Congenital Diarrhea and Enteropathies Panel PreventionGenetics United States | 241 | 157 |
|
Invitae Broad Carrier Screen without X-linked Disorders Invitae United States | 195 | 98 |
|
Invitae United States | 224 | 112 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 886 | 547 |
|
Skin and Connective Tissue Disorders Panel PreventionGenetics United States | 125 | 69 |
|
Epidermolysis bullosa dystrophica, autosomal dominant & recessive Comprehensive test HNL Genomics Connective Tissue Gene Tests United States | 2 | 1 |
|
Epidermolysis bullosa dystrophica, autosomal dominant & recessive Deletion / Duplication test HNL Genomics Connective Tissue Gene Tests United States | 2 | 1 |
|
Epidermolysis bullosa dystrophica, autosomal dominant & recessive NGS test HNL Genomics Connective Tissue Gene Tests United States | 2 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.